6,388
Views
32
CrossRef citations to date
0
Altmetric
Antimicrobial Agents

Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2205-2219 | Received 14 Sep 2021, Accepted 01 Nov 2021, Published online: 04 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rosesathorn Soontarach, Ozioma Forstinus Nwabor & Supayang Piyawan Voravuthikunchai. (2022) Interaction of lytic phage T1245 with antibiotics for enhancement of antibacterial and anti-biofilm efficacy against multidrug-resistant Acinetobacter baumannii. Biofouling 38:10, pages 994-1005.
Read now

Articles from other publishers (31)

Xiaoming Yuan, Zhichao Huang, Zhenjun Zhu, Jumei Zhang, Qingping Wu, Liang Xue, Juan Wang & Yu Ding. (2023) Recent advances in phage defense systems and potential overcoming strategies. Biotechnology Advances 65, pages 108152.
Crossref
Lamiaa A. Al-Madboly, Ahmed A. Abdelaziz, Amal M. Abo-Kamer, Ahmed M. Nosair & Karim Abdelkader. (2023) Characterization and genomic analysis of novel bacteriophage NK20 to revert colistin resistance and combat pandrug-resistant Klebsiella pneumoniae in a rat respiratory infection model. Life Sciences 322, pages 121639.
Crossref
Naveen Kumar Devanga Ragupathi, Dhiviya Prabaa Muthuirulandi Sethuvel, Mohanraj Gopikrishnan, Hariharan Triplicane Dwarakanathan, Dhivya Murugan, Indranil Biswas, Yamuna Devi Bakthavachalam, Malathi Murugesan, C. George Priya Doss, Peter N. Monk, Esther Karunakaran & Balaji Veeraraghavan. (2023) Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens. Microbial Pathogenesis 178, pages 106064.
Crossref
Wajid Hussain, Xiaohan Yang, Mati Ullah, Huan Wang, Ayesha Aziz, Fang Xu, Muhammad Asif, Muhammad Wajid Ullah & Shenqi Wang. (2023) Genetic engineering of bacteriophages: Key concepts, strategies, and applications. Biotechnology Advances 64, pages 108116.
Crossref
Abdallah S. Abdelsattar, Mohamed Atef Eita, Zainab K. Hammouda, Shrouk Mohamed Gouda, Toka A. Hakim, Aghapy Yermans Yakoup, Anan Safwat & Ayman El-Shibiny. (2023) The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin. Viruses 15:4, pages 912.
Crossref
Qihang Tu, Mingfang Pu, Yahao Li, Yuer Wang, Maochen Li, Lihua Song, Mengzhe Li, Xiaoping An, Huahao Fan & Yigang Tong. (2023) Acinetobacter Baumannii Phages: Past, Present and Future. Viruses 15:3, pages 673.
Crossref
Yuer Wang, Huahao Fan & Yigang Tong. (2023) Unveil the Secret of the Bacteria and Phage Arms Race. International Journal of Molecular Sciences 24:5, pages 4363.
Crossref
Michal Andrezal, Lucia Oravcova, Veronika Kadličekova, Elham Ozaee, Sulafa Elnwrani, Juraj Bugala, Barbora Markuskova, Michal Kajsik & Hana Drahovska. (2023) Characterization and the host specificity of Pet-CM3–4, a new phage infecting Cronobacter and Enterobacter strains. Virus Research 324, pages 199025.
Crossref
Jintao He, Qiucheng Shi, Zhifu Chen, Wang Zhang, Peng Lan, Qingye Xu, Huangdu Hu, Qiong Chen, Jianzhong Fan, Yan Jiang, Belinda Loh, Sebastian Leptihn, Quanming Zou, Jinyong Zhang, Yunsong Yu & Xiaoting Hua. (2023) Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae. Drug Resistance Updates 66, pages 100891.
Crossref
Yujing Tan, Jianhui Su, Minghui Fu, Hongmei Zhang & Haiyan Zeng. (2022) Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii. Bioengineering 10:1, pages 35.
Crossref
Xin Yin, Qingqing Fang & Zhiyong Zong. (2022) Interruption of Capsular Polysaccharide Biosynthesis Gene wbaZ by Insertion Sequence IS 903B Mediates Resistance to a Lytic Phage against ST11 K64 Carbapenem-Resistant Klebsiella pneumoniae . mSphere 7:6.
Crossref
Juhi Sharma, Divakar Sharma, Amit Singh & Kumari Sunita. (2022) Colistin Resistance and Management of Drug Resistant Infections. Canadian Journal of Infectious Diseases and Medical Microbiology 2022, pages 1-10.
Crossref
Marzanna Łusiak-Szelachowska, Ryszard Międzybrodzki, Zuzanna Drulis-Kawa, Kathryn Cater, Petar Knežević, Cyprian Winogradow, Karolina Amaro, Ewa Jończyk-Matysiak, Beata Weber-Dąbrowska, Justyna Rękas & Andrzej Górski. (2022) Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. Journal of Biomedical Science 29:1.
Crossref
Dongyang Gao, Hongyue Ji, Linkang Wang, Xinxin Li, Dayue Hu, Junna Zhao, Shuang Wang, Pan Tao, Xiangmin Li & Ping Qian. (2022) Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence. Microbiology Spectrum 10:5.
Crossref
Jarin Taslem Mourosi, Ayobami Awe, Wenzheng Guo, Himanshu Batra, Harrish Ganesh, Xiaorong Wu & Jingen Zhu. (2022) Understanding Bacteriophage Tail Fiber Interaction with Host Surface Receptor: The Key “Blueprint” for Reprogramming Phage Host Range. International Journal of Molecular Sciences 23:20, pages 12146.
Crossref
Liwei Zhang, Xiaoqing Wang, Xiaoting Hua, Yunsong Yu, Sebastian Leptihn & Belinda Loh. (2022) Therapeutic evaluation of the Acinetobacter baumannii phage Phab24 for clinical use. Virus Research 320, pages 198889.
Crossref
Nachimuthu Ramesh, Prasanth Manohar, Kandasamy Eniyan, Loganathan Archana, Sudarsanan Athira, Belinda Loh, Long Ma & Sebastian Leptihn. (2022) A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140. Antimicrobial Agents and Chemotherapy 66:9.
Crossref
Jacob J. Zulk, Justin R. Clark, Samantha Ottinger, Mallory B. Ballard, Marlyd E. Mejia, Vicki Mercado-Evans, Emmaline R. Heckmann, Belkys C. Sanchez, Barbara W. Trautner, Anthony W. Maresso & Kathryn A. Patras. (2022) Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. mSphere 7:4.
Crossref
Mengju Liu, Ye Tian, Haitham E. M. Zaki, Temoor Ahmed, Rong Yao, Chengqi Yan, Sebastian Leptihn, Belinda Loh, Muhammad Shafiq Shahid, Fang Wang, Jianping Chen & Bin Li. (2022) Phage Resistance Reduced the Pathogenicity of Xanthomonas oryzae pv. oryzae on Rice. Viruses 14:8, pages 1770.
Crossref
Greater Kayode Oyejobi, Sunday Olabode Olaniyan, Nana-Aishat Yusuf, Deborah Adepeju Ojewande, Mobolaji Johnson Awopetu, Goodness Opeyemi Oyeniran, Fazal Mehmood Khan, Peter Alabi Dare & Maryam Kikelomo Adegbite-Badmus. (2022) Acinetobacter baumannii: More ways to die. Microbiological Research 261, pages 127069.
Crossref
Mahadi Hasan & Juhee Ahn. (2022) Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria. Antibiotics 11:7, pages 915.
Crossref
Mei Liu, Adriana Hernandez-Morales, James Clark, Tram Le, Biswajit Biswas, Kimberly A. Bishop-Lilly, Matthew Henry, Javier Quinones, Logan J. Voegtly, Regina Z. Cer, Theron Hamilton, Robert T. Schooley, Scott Salka, Ry Young & Jason J. Gill. (2022) Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy. Nature Communications 13:1.
Crossref
Meity Mardiana, Soon-Hian Teh, Ling-Chun Lin & Nien-Tsung Lin. (2022) Isolation and Characterization of a Novel Siphoviridae Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant Acinetobacter baumannii. Viruses 14:6, pages 1240.
Crossref
Sebastian Leptihn & Belinda Loh. (2022) Complexity, challenges and costs of implementing phage therapy. Future Microbiology 17:9, pages 643-646.
Crossref
Fernando L. Gordillo Altamirano, Xenia Kostoulias, Dinesh Subedi, Denis Korneev, Anton Y. Peleg & Jeremy J. Barr. (2022) Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. eBioMedicine 80, pages 104045.
Crossref
Benjamin Havenga, Brandon Reyneke, Monique Waso-Reyneke, Thando Ndlovu, Sehaam Khan & Wesaal Khan. (2022) Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies. Microorganisms 10:5, pages 1052.
Crossref
Jun-Fang Dong, Cheng-jie Feng, Ping Wang, Ren-Qing Li & Qing-Hua Zou. (2022) Comparative genomics analysis of Acinetobacter baumannii multi-drug resistant and drug sensitive strains in China. Microbial Pathogenesis 165, pages 105492.
Crossref
Prasanth Manohar, Belinda Loh, Namasivayam Elangovan, Archana Loganathan, Ramesh Nachimuthu & Sebastian Leptihn. (2022) A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens. Microbiology Spectrum 10:1.
Crossref
Antón Ambroa, Lucia Blasco, María López, Olga Pacios, Inés Bleriot, Laura Fernández-García, Manuel González de Aledo, Concha Ortiz-Cartagena, Andrew Millard & María Tomás. (2022) Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection. Frontiers in Microbiology 12.
Crossref
Prasanth Manohar, Madhav Madurantakam Royam, Belinda Loh, Bulent Bozdogan, Ramesh Nachimuthu & Sebastian Leptihn. (2022) Synergistic Effects of Phage–Antibiotic Combinations against Citrobacter amalonaticus . ACS Infectious Diseases 8:1, pages 59-65.
Crossref
Sandra-Maria Wienhold, Markus C. Brack, Geraldine Nouailles, Gopinath Krishnamoorthy, Imke H. E. Korf, Claudius Seitz, Sarah Wienecke, Kristina Dietert, Corinne Gurtner, Olivia Kershaw, Achim D. Gruber, Anton Ross, Holger Ziehr, Manfred Rohde, Jens Neudecker, Jasmin Lienau, Norbert Suttorp, Stefan Hippenstiel, Andreas C. Hocke, Christine Rohde & Martin Witzenrath. (2021) Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection. Viruses 14:1, pages 33.
Crossref